<it>NAT </it>gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel <it>NAT1 </it>allelic variant
Budge Marc, Jonovska Vesna, Bell Peter and 2 more
BMC Medical Genetics · 2004
doi:10.1186/1471-2350-5-6 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>Alzheimer's disease is multifactorial, having environmental, toxicological and genetic risk factors. Impaired folate and homocysteine metabolism has been hypothesised to increase risk. In addition to its xenobiotic-metabolising capacity, human arylamine <it>N</it>-acetyltransferase type-1 (NAT1) acetylates the folate catabolite <it>para</it>-aminobenzoylglutamate and is implicated in folate metabolism. The purpose of this study was to determine whether polymorphisms in the human <it>NAT </it>genes influence susceptibility to Alzheimer's disease.</p> <p>Methods</p> <p>Elderly individuals with and without Alzheimer's disease were genotyped at the polymorphic <it>NAT1 </it>(147 cases; 111 controls) and <it>NAT2 </it>(45 cases; 63 controls) loci by polymerase chain reaction-restriction fragment length polymorphism, and the genotype and allele frequencies were compared using the chi-squared test.</p> <p>Results</p> <p>Although a trend towards fast NAT2 acetylator-associated Alzheimer's disease susceptibility was indicated and the <it>NAT1*10/1*10 </it>genotype was observed only in cases of Alzheimer's disease (6/147, 4.1%), no significant difference in the frequency of <it>NAT2 </it>(<it>p </it>= 0.835) or <it>NAT1 </it>(<it>p </it>= 0.371) genotypes was observed between cases and controls. In addition, a novel <it>NAT1 </it>variant, <it>NAT1*11B</it>, was identified.</p> <p>Conclusions</p> <p>These results suggest that genetic polymorphisms in <it>NAT1 </it>and <it>NAT2 </it>do not influence susceptibility to Alzheimer's disease, although the increase in frequency of the <it>NAT1*10 </it>allele in Alzheimer's disease is worthy of further investigation. Due to its similarity with the <it>NAT1*11A </it>allele, <it>NAT1*11B </it>is likely to encode an enzyme with reduced NAT1 activity.</p>
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.